List of Charts
Chart 1-1: Orthopedic Biomaterials Market by Segment, U.S., 2023 - 2030
Chart 1-2: Orthopedic Biomaterials Market Overview, U.S., 2023 & 2030
Chart 2-1: Multi-Scenario Orthopedic Biomaterials Market Forecast, U.S., 2020 - 2030 (US$M)
Chart 5-1: Orthopedic Biomaterials Market by Segment, U.S., 2020 - 2030
Chart 5-2: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2023
Chart 6-1: Orthopedic Biomaterials Procedures by Segment, U.S., 2020 - 2030
Chart 7-1: Orthopedic Bone Graft Substitute Market by Segment, U.S., 2020 - 2030
Chart 7-2: Orthopedic Bone Graft Substitute Market by Indication, U.S., 2020 - 2030
Chart 7-3: Leading Competitors, Orthopedic Bone Graft Substitute Market, U.S., 2023
Chart 8-1: Orthopedic Growth Factor Market by Segment, U.S., 2020 - 2030
Chart 8-2: Leading Competitors, Orthopedic Growth Factor Market, U.S., 2023
Chart 9-1: Orthopedic Cellular Allograft Market by Segment, U.S., 2020 - 2030
Chart 9-2: Leading Competitors, Orthopedic Cellular Allograft Market, U.S., 2023
Chart 10-1: Orthopedic Cell Therapy Market by Segment, U.S., 2020 - 2030
Chart 10-2: Leading Competitors, Orthopedic Cell Therapy Market, U.S., 2023
Chart 11-1: Hyaluronic Acid (HA) Viscosupplementation Market by Segment, U.S., 2020 - 2030
Chart 11-2: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, U.S., 2023
Chart 12-1: Orthopedic Cartilage Repair Market by Segment, U.S., 2020 - 2030
Chart 12-2: Leading Competitors, Orthopedic Cartilage Repair Market, U.S., 2023
List of Figures
Figure 1-1: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2023 (1 of 2)
Figure 1-2: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2023 (2 of 2)
Figure 1-3: Companies Researched in This Report
Figure 1-4: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (1 of 2)
Figure 1-5: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (2 of 2)
Figure 1-6: Recent Events in the Orthopedic Biomaterials Market, U.S., 2021 - 2024 (1 of 6)
Figure 1-7: Recent Events in the Orthopedic Biomaterials Market, U.S., 2021 - 2024 (2 of 6)
Figure 1-8: Recent Events in the Orthopedic Biomaterials Market, U.S., 2021 - 2024 (3 of 6)
Figure 1-9: Recent Events in the Orthopedic Biomaterials Market, U.S., 2021 - 2024 (4 of 6)
Figure 1-10: Recent Events in the Orthopedic Biomaterials Market, U.S., 2021 - 2024 (5 of 6)
Figure 1-11: Recent Events in the Orthopedic Biomaterials Market, U.S., 2021 - 2024 (6 of 6)
Figure 1-12: Orthopedic Biomaterials Procedures Covered (1 of 4)
Figure 1-13: Orthopedic Biomaterials Procedures Covered (2 of 4)
Figure 1-14: Orthopedic Biomaterials Procedures Covered (3 of 4)
Figure 1-15: Orthopedic Biomaterials Procedures Covered (4 of 4)
Figure 1-16: Procedure Codes Investigated
Figure 1-17: Orthopedic Biomaterials Markets Covered (1 of 6)
Figure 1-18: Orthopedic Biomaterials Markets Covered (2 of 6)
Figure 1-19: Orthopedic Biomaterials Markets Covered (3 of 6)
Figure 1-20: Orthopedic Biomaterials Markets Covered (4 of 6)
Figure 1-21: Orthopedic Biomaterials Markets Covered (5 of 6)
Figure 1-22: Orthopedic Biomaterials Markets Covered (6 of 6)
Figure 1-23: Key Report Updates
Figure 1-24: Version History
Figure 2-1: Orthopedic Biomaterials Market by Segment, Worst Case Scenario, U.S., 2020 - 2030 (US$M)
Figure 2-2: Orthopedic Biomaterials Market by Segment, Base Case Scenario, U.S., 2020 - 2030 (US$M)
Figure 2-3: Orthopedic Biomaterials Market by Segment, Best Case Scenario, U.S., 2020 - 2030 (US$M)
Figure 4-1: Bone Graft Substitutes Products by Company (1 of 4)
Figure 4-2: Bone Graft Substitutes Products by Company (2 of 4)
Figure 4-3: Bone Graft Substitutes Products by Company (3 of 4)
Figure 4-4: Bone Graft Substitutes Products by Company (4 of 4)
Figure 4-5: Growth Factor Products by Company
Figure 4-6: Cellular Allograft Products by Company
Figure 4-7: Cell Therapy Products by Company
Figure 4-8: Hyaluronic Acid Viscosupplementation by Products by Company
Figure 4-9: Cartilage Repair Products by Company
Figure 4-10: Class 2 Device Recall GRAFTON DBM (Gel, Flex, Putty, Matrix, Crunch)
Figure 4-11: Class 2 Device Recall GRAFTON PLUS DBM Paste
Figure 4-12: Class 2 Device Recall Magnifuse Bone Graft
Figure 4-13: Class 2 Device Recall Grafton DBF Inject
Figure 4-14: Class 2 Device Recall OsteoSelect Demineralized Bone Matrix (DBM) Putty
Figure 4-15: Class 2 Device Recall PROSTIM 10cc INJECTABLE
Figure 4-16: Class 2 Device Recall Opteform Allograft Disc
Figure 4-17: Class 2 Device Recall Bioactive Bone Graft Putty
Figure 4-18: Class 3 Device Recall iFACTOR Peptide Enhanced Bone Graft Putty
Figure 4-19: ACDF Using Structural Allograft vs. Tritanium C
Figure 4-20: Clinical Study of Bone Graft Substitutes in Orthopaedic and Spinal Applications
Figure 4-21: OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study
Figure 4-22: Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft. (BONE)
Figure 4-23: Demineralized Bone Matrix Rotator Cuff Study
Figure 4-24: Clinical Outcomes Associated with the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease
Figure 4-25: The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction
Figure 4-26: Long-term Safety and Effectiveness of AUGMENT® Injectable Bone Graft Compared to Autologous Bone Graft
Figure 4-27: Transforaminal Lumbar Interbody Fusion (TLIF)
Figure 4-28: A Post Market Surveillance on INFUSE Bone Graft
Figure 4-29: Long-term Safety and Effectiveness of AUGMENT® Injectable Bone Graft Compared to Autologous Bone Graft
Figure 4-30: Evaluation of the Effectiveness of AMPLEX® Compared to Autogenous Bone Grafts
Figure 4-31: Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care
Figure 4-32: MagnetOs Putty Compared to Trinity Evolution in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
Figure 4-33: Clinical Outcomes Associated with the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease (ViviGen)
Figure 4-34: Trinity Elite in Lumbar Fusion
Figure 4-35: An ACDF Multi-Center Study Using ViviGen Cellular Bone Matrix
Figure 4-36: ViviGen Cellular Bone Matrix for Hindfoot or Ankle Arthrodesis (ViviGen)
Figure 4-37: Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
Figure 4-38: Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
Figure 4-39: BMAC & Allograft vs BMP-2
Figure 4-40: Bone Marrow Aspirate Concentrate (BMAC)Treatment for Knee Osteoarthritis (BMAC)
Figure 4-41: Platelet Rich Plasma in Knee Osteoarthritis
Figure 4-42: Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine
Figure 4-43: A Prospective Study of Clinical Outcomes Following a Single Intradiscal Injection of Bone Marrow Aspirate Concentrate (BMAC) for Single Level Discogenic Low Back Pain
Figure 4-44: ArtiAid® for Knee Osteoarthritis: A Post-market Study
Figure 4-45: The Effectiveness of Different Doses of Hyaluronic Acid Injections in Knee Osteoarthritis
Figure 4-46: Euflexxa for the Treatment of Osteoarthritis
Figure 4-47: MONOVISC for Ankle Joint Pain Relief
Figure 4-48: MONOVISC for Shoulder Joint Pain Relief
Figure 4-49: MONOVISC for Hip Joint Pain Relief
Figure 4-50: Comparison of Hyaluronic Acid and Platelet-Rich Plasma Injections
Figure 4-51: Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
Figure 4-52: Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis
Figure 4-53: Phase 2 Clinical Trial of CartiLife® in the United States
Figure 4-54: A Study to Evaluate the Efficacy of BioCartilage® Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects
Figure 5-1: Orthopedic Biomaterials Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 5-2: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2023 (1 of 2)
Figure 5-3: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2023 (2 of 2)
Figure 5-4: SWOT Analysis, Arthrex
Figure 5-5: SWOT Analysis, Biocomposites
Figure 5-6: SWOT Analysis, Bioventus
Figure 5-7: SWOT Analysis, DePuy Synthes
Figure 5-8: SWOT Analysis, Ferring Pharmaceuticals
Figure 5-9: SWOT Analysis, Isto Biologics
Figure 5-10: SWOT Analysis, Medtronic
Figure 5-11: SWOT Analysis, MTF
Figure 5-12: SWOT Analysis, NuVasive
Figure 5-13: SWOT Analysis, Orthofix
Figure 5-14: SWOT Analysis, Sanofi
Figure 5-15: SWOT Analysis, Stryker
Figure 5-16: SWOT Analysis, Terumo
Figure 5-17: SWOT Analysis, Vericel
Figure 5-18: SWOT Analysis, Zimmer Biomet
Figure 6-1: Procedure Codes Investigated, U.S., 2023
Figure 6-2: Orthopedic Biomaterials Procedures by Segment, U.S., 2020 - 2030
Figure 6-3: Orthopedic Bone Grafting Procedures by Material, U.S., 2020 - 2030
Figure 6-4: Orthopedic Bone Grafting Procedures by Indication, U.S., 2020 - 2030 (1 of 2)
Figure 6-5: Orthopedic Bone Grafting Procedures by Indication, U.S., 2020 - 2030 (2 of 2)
Figure 6-6: Average Units Used per Procedure by Indication, U.S., 2020 - 2030
Figure 6-7: Autograft Procedures by Indication, U.S., 2020 - 2030 (1 of 2)
Figure 6-8: Autograft Procedures by Indication, U.S., 2020 - 2030 (2 of 2)
Figure 6-9: Allograft Procedures by Indication, U.S., 2020 - 2030 (1 of 2)
Figure 6-10: Allograft Procedures by Indication, U.S., 2020 - 2030 (2 of 2)
Figure 6-11: Xenograft Procedures by Indication, U.S., 2020 - 2030 (1 of 2)
Figure 6-12: Xenograft Procedures by Indication, U.S., 2020 - 2030 (2 of 2)
Figure 6-13: DBM Procedures by Indication, U.S., 2020 - 2030 (1 of 2)
Figure 6-14: DBM Procedures by Indication, U.S., 2020 - 2030 (2 of 2)
Figure 6-15: Synthetic Procedures by Indication, U.S., 2020 - 2030 (1 of 2)
Figure 6-16: Synthetic Procedures by Indication, U.S., 2020 - 2030 (2 of 2)
Figure 6-17: Allograft Procedures by Patient Type, U.S., 2020-2030
Figure 6-18: Xenograft Procedures by Patient Type, U.S., 2020-2030
Figure 6-19: DBM Procedures by Patient Type, U.S., 2020-2030
Figure 6-20: Synthetic Procedures by Patient Type, U.S., 2020-2030
Figure 6-21: Orthopedic Bone Grafting Procedures by Care Setting, U.S., 2020-2030
Figure 6-22: Orthopedic Growth Factor Procedures by Indication, U.S., 2020 - 2030
Figure 6-23: Orthopedic Growth Factor Procedures by Care Setting, U.S., 2020 - 2030
Figure 6-24: Cellular Allograft Procedures by Anatomy, U.S., 2020 - 2030
Figure 6-25: Cellular Allograft Procedures by Patient Type, U.S., 2020 - 2030
Figure 6-26: Cellular Allograft Procedures by Care Setting, U.S., 2020 - 2030
Figure 6-27: Orthopedic Cell Therapy Procedures by Material Type, U.S., 2020 - 2030
Figure 6-28: Platelet-Rich Plasma Procedures by Indication, U.S., 2020 - 2030 (1 of 2)
Figure 6-29: Platelet-Rich Plasma Procedures by Indication, U.S., 2020 - 2030 (2 of 2)
Figure 6-30: Bone Marrow Aspirate Concentrate Procedures by Indication, U.S., 2020 - 2030 (1 of 2)
Figure 6-31: Bone Marrow Aspirate Concentrate Procedures by Indication, U.S., 2020 - 2030 (2 of 2)
Figure 6-32: Orthopedic Cell Therapy Procedures by Patient Type, U.S., 2020 - 2030
Figure 6-33: Orthopedic Cell Therapy Procedures by Care Setting, U.S., 2020 - 2030
Figure 6-34: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, U.S., 2020 - 2030 (1 of 2)
Figure 6-35: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, U.S., 2020 - 2030 (2 of 2)
Figure 6-36: Hyaluronic Acid Viscosupplementation Procedures by Patient Type, U.S., 2020 - 2030
Figure 6-37: Hyaluronic Acid Viscosupplementation Procedures by Care Setting, U.S., 2020 - 2030
Figure 6-38: Orthopedic Cartilage Repair Procedures by Type, U.S., 2020 - 2030 (1 of 2)
Figure 6-39: Orthopedic Cartilage Repair Procedures by Type, U.S., 2020 - 2030 (2 of 2)
Figure 6-40: Orthopedic Cartilage Repair Procedures by Patient Type, U.S., 2020 - 2030
Figure 6-41: Orthopedic Cartilage Repair Procedures by Care Setting, U.S., 2020 - 2030
Figure 7-1: Orthopedic Bone Graft Substitute Units per Procedure by Indication, U.S., 2020 - 2030
Figure 7-2: Orthopedic Bone Graft Substitute Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 7-3: Orthopedic Bone Graft Substitute Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 7-4: Orthopedic Bone Graft Substitute Market, U.S., 2020 - 2030
Figure 7-5: Allograft Bone Graft Substitute Market, U.S., 2020 - 2030
Figure 7-6: Xenograft Bone Graft Substitute Market, U.S., 2020 - 2030
Figure 7-7: Demineralized Bone Matrix Allograft Bone Graft Substitute Market, U.S., 2020 - 2030
Figure 7-8: Synthetic Bone Graft Substitute Market, U.S., 2020 - 2030
Figure 7-9: Synthetic Bone Graft Substitute Market by Generation Type, U.S., 2020 - 2030 (US$M)
Figure 7-10: Generation 1 Synthetic Bone Graft Substitute Market, U.S., 2020 - 2030
Figure 7-11: Generation 2 Synthetic Bone Graft Substitute Market, U.S., 2020 - 2030
Figure 7-12: Allograft Bone Graft Substitute Units Sold by Indication, U.S., 2020 - 2030
Figure 7-13: Spine Allograft Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-14: Spine Allograft Bone Graft Substitute Units Sold by Product Type, U.S., 2020 - 2030
Figure 7-15: Trauma Allograft Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-16: Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-17: Allograft Bone Graft Substitute Units Sold by Patient Type, U.S., 2020 - 2030
Figure 7-18: Allograft Bone Graft Substitute Units Sold by Setting Type, U.S., 2020 - 2030
Figure 7-19: Allograft Bone Graft Substitute Units Sold by Product Type, U.S., 2020 - 2030 (1 of 2)
Figure 7-20: Allograft Bone Graft Substitute Units Sold by Product Type, U.S., 2020 - 2030 (2 of 2)
Figure 7-21: Xenograft Bone Graft Substitute Units Sold by Indication, U.S., 2020 - 2030
Figure 7-22: Spine Xenograft Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-23: Spine Xenograft Bone Graft Substitute Units Sold by Product Type, U.S., 2020 - 2030
Figure 7-24: Trauma Xenograft Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-25: Large Joint Reconstruction Xenograft Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-26: Xenograft Bone Graft Substitute Units Sold by Patient Type, U.S., 2020 - 2030
Figure 7-27: Xenograft Bone Graft Substitute Units Sold by Setting Type, U.S., 2020 - 2030
Figure 7-28: Xenograft Bone Graft Substitute Units Sold by Product Type, U.S., 2020 - 2030
Figure 7-29: DBM with Carriers Market, U.S., 2020-2030
Figure 7-30: DBM without Carriers Market, U.S., 2020-2030
Figure 7-31: Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Indication, U.S., 2020 - 2030
Figure 7-32: Spine Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-33: Spine Demineralized Bone Matrix Bone Graft Substitute Units Sold by Product Type, U.S., 2020 - 2030
Figure 7-34: Trauma Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-35: Large Joint Reconstruction Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-36: Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Patient Type, U.S., 2020 - 2030
Figure 7-37: Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Setting Type, U.S., 2020 - 2030
Figure 7-38: Demineralized Bone Matrix Bone Graft Substitute Units Sold by Product Type, U.S., 2020 - 2030 (1 of 2)
Figure 7-39: Demineralized Bone Matrix Bone Graft Substitute Units Sold by Product Type, U.S., 2020 - 2030 (2 of 2)
Figure 7-40: Synthetic Bone Graft Substitute Units Sold by Indication, U.S., 2020 - 2030
Figure 7-41: Spine Synthetic Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-42: Spine Synthetic Bone Graft Substitute Units Sold by Product Type, U.S., 2020 - 2030
Figure 7-43: Trauma Synthetic Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-44: Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold, U.S., 2020 - 2030
Figure 7-45: Synthetic Bone Graft Substitute Units Sold by Patient Type, U.S., 2020 - 2030
Figure 7-46: Synthetic Bone Graft Substitute Units Sold by Setting Type, U.S., 2020 - 2030
Figure 7-47: Synthetic Bone Graft Substitute Units Sold by Patient Type, U.S., 2020 - 2030
Figure 7-48: Synthetic Bone Graft Substitute Units Sold by Product Type, U.S., 2020 - 2030 (1 of 2)
Figure 7-49: Synthetic Bone Graft Substitute Units Sold by Product Type, U.S., 2020 - 2030 (2 of 2)
Figure 7-50: Leading Competitors, Orthopedic Bone Graft Substitute Market, U.S., 2023
Figure 8-1: Orthopedic Growth Factor Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 8-2: Orthopedic Growth Factor Market, U.S., 2020 - 2030
Figure 8-3: Cervical Disc Degeneration Orthopedic Growth Factor Market, U.S., 2020 - 2030
Figure 8-4: Tibial Fracture Orthopedic Growth Factor Market, U.S., 2020 - 2030
Figure 8-5: Spine Orthopedic Growth Factor Market, U.S., 2020 - 2030
Figure 8-6: Ankle & Hindfoot Fusion Orthopedic Growth Factor Market, U.S., 2020 - 2030
Figure 8-7: Cervical Disc Degeneration Growth Factor Units Sold by Setting Type, U.S., 2020 - 2030
Figure 8-8: Tibial Fracture Growth Factor Units Sold by Setting Type, U.S., 2020 - 2030
Figure 8-9: Spine Growth Factor Units Sold by Setting Type, U.S., 2020 - 2030
Figure 8-10: Ankle and Hindfoot Fusion Growth Factor Units Sold by Setting Type, U.S., 2020 - 2030
Figure 8-11: Leading Competitors, Orthopedic Growth Factor Market, U.S., 2023
Figure 9-1: Orthopedic Cellular Allograft Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 9-2: Orthopedic Cellular Allograft Market, U.S., 2020 - 2030
Figure 9-3: Cervical Spine Orthopedic Cellular Allograft Market, U.S., 2020 - 2030
Figure 9-4: Lumbar Spine Orthopedic Cellular Allograft Market, U.S., 2020 - 2030
Figure 9-5: Foot and Ankle Cellular Allograft Market, U.S., 2020 - 2030
Figure 9-6: Trauma Cellular Allograft Market, U.S., 2020 - 2030
Figure 9-7: Leading Competitors, Orthopedic Cellular Allograft Market, U.S., 2023
Figure 10-1: Orthopedic Cell Therapy Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 10-2: Platelet-Rich Plasma Market, U.S., 2020 - 2030
Figure 10-3: Bone Marrow Aspirate Concentrate Market, U.S., 2020 - 2030
Figure 10-4: Platelet-Rich Plasma Units Sold by Indication Anatomy, U.S., 2020 - 2030
Figure 10-5: Bone Marrow Aspirate Concentrate Units Sold by Indication Anatomy, U.S., 2020 - 2030
Figure 10-6: Leading Competitors, Orthopedic Cell Therapy Market, U.S., 2023
Figure 11-1: Hyaluronic Acid Viscosupplementation Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 11-2: Hyaluronic Acid Viscosupplementation Market, U.S., 2020 - 2030
Figure 11-3: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2020 - 2030
Figure 11-4: Two-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2020 - 2030
Figure 11-5: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2020 - 2030
Figure 11-6: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2020 - 2030
Figure 11-7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, U.S., 2023
Figure 12-1: Orthopedic Cartilage Repair Market by Segment, U.S., 2020 - 2030 (US$M)
Figure 12-2: Osteochondral Allograft Market, U.S., 2020 - 2030
Figure 12-3: Meniscal Allograft Market, U.S., 2020 - 2030
Figure 12-4: Autologous Chondrocyte Implantation Market, U.S., 2020 - 2030
Figure 12-5: Particulated Juvenile Allograft Market, U.S., 2020 - 2030
Figure 12-6: Microfracture Adjunct Market, U.S., 2020 - 2030
Figure 12-7: Osteochondral Allograft Cartilage Repair Units Sold by Patient Type, U.S., 2020 - 2030
Figure 12-8: Meniscal Allograft Cartilage Repair Units Sold by Patient Type, U.S., 2020 - 2030
Figure 12-9: Autologous Chondrocyte Implantation Cartilage Repair Units Sold by Patient Type, U.S., 2020 - 2030
Figure 12-10: Particulated Juvenile Cartilage Repair Units Sold by Patient Type, U.S., 2020 - 2030
Figure 12-11: Microfracture Adjunct Cartilage Repair Units Sold by Patient Type, U.S., 2020 - 2030
Figure 12-12: Leading Competitors, Orthopedic Cartilage Repair Market, U.S., 2023
